Improving Smoking Abstinence Outcomes in the African American Community Through Extended Treatment
Part of paid clinical trials in Kansas City, Missouri.
- Sponsor
- University of Kansas Medical Center
- Study ID
- NCT05732272
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- Smoking Cessation
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Bupropion — DRUG150 mg once daily for 3 days, then twice daily for the remainder of the treatment phase.
Study Details
This study will evaluate the efficacy of extended bupropion(6 months) versus standard bupropion treatment (7 weeks) among African American daily smokers.
Key Dates
- Start date
- Feb 28, 2023
- Status verified
- Feb 2026
- Primary completion
- Jan 31, 2027
- Completion
- Apr 30, 2027
Study Design
- Enrollment
- 500 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Standard Treatment250 participants will be randomly assigned to the standard treatment arm and receive 7 weeks of bupropion SR following standard dosing guidelines(150 mg once daily for 3 days, then 150mg twice daily for 7 weeks). Participants in this arm will also receive 8 smoking cessation counseling sessions consistent with the Clinical Practice Guidelines.
- Active Comparator: Extended Treatment250 participants will be randomly assigned to the extended treatment arm and receive 24 weeks of bupropion SR following standard dosing guidelines(150 mg once daily for 3 days, then 150mg twice daily for 24 weeks). Participants in this arm will also receive 8 smoking cessation counseling sessions consistent with the Clinical Practice Guidelines.
Primary Outcome Measure
Verified abstinence at Month 6 [ Time Frame: Month 6 ]
Central Contacts
- Tricia Snow, MPH816-398-8960
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Kansas Medical Center | Kansas City | Missouri | 64130 |
Find similar trials in Kansas City, MO
By research site
Related Studies
- Precision Prevention Strategy to Increase Uptake and Engagement in Lung Cancer Screening and Smoking Cessation TreatmentEnrolling By Invitation · Washington University School of Medicine · St Louis, Missouri
- Personalized Tobacco Treatment in Primary Care (MOTIVATE)Recruiting · Washington University School of Medicine · St Louis, Missouri
- CONNECT Cancer Survivors With Tobacco TreatmentRecruiting · Washington University School of Medicine · St Louis, Missouri
- Precision Treatment to Promote Smoking Cessation and Survival in Oncology PatientsRecruiting · Washington University School of Medicine · St Louis, Missouri